Novel approaches for targeting BRCA2-deficient tumour cells
<p>Defects in homologous recombination (HR) repair are associated with significant mortality and improved therapies for HR-deficient tumours are therefore urgently needed. This work aimed to address this unmet need and utilised pharmacological approaches to investigate several methods for the...
Main Author: | Tacconi, E |
---|---|
Other Authors: | Tarsounas, M |
Format: | Thesis |
Language: | English |
Published: |
2015
|
Similar Items
-
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
by: Tacconi, E, et al.
Published: (2019) -
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
by: Eliana MC Tacconi, et al.
Published: (2019-07-01) -
Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds
by: Zimmer, J, et al.
Published: (2016) -
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy
by: Salar Farokhi Boroujeni, et al.
Published: (2023-11-01) -
Novel approaches to targeting ATM-deficient tumours
by: Harris, LE
Published: (2022)